z-logo
open-access-imgOpen Access
Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient
Author(s) -
King Amber C.,
Diamond Eli L.,
Orozco Jennifer S.,
Morse Hannah R.,
Ouyang Linda L.,
Schöder Heiko,
Rampal Raajit K.
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2297
Subject(s) - medicine , erdheim–chester disease , adverse effect , surgery , disease , histiocytosis
Our rechallenge of cobimetinib in an Erdheim‐Chester Disease (ECD) patient for the rare adverse effect, “dropped head syndrome,” with a previously unexplored cobimetinib regimen was successful. Similar to other experiences with targeted agents in ECD, dosing of cobimetinib may vary to mitigate toxicity without impairing efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here